[Antihypertensive effect of isradipine: blood pressure determination with continuous ambulatory monitoring].
A 24 hr blood pressure monitoring system (Medilog ABP) was used to evaluate the efficacy of isradipine, 2.5 mg q 12 hr for 2 weeks, in 26 hypertensive patients. During a pretreatment control period of 4 weeks a diastolic pressure above 95 mmHg on non pharmacologic measures was verified in each patient. A significant decrease in systolic and diastolic blood pressures compared at 2 hr intervals was observed after treatment with isradipine. Treatment was not associated to modification of the circadian rythm in blood pressures.